Delivery Order SPE2DR25D1021-SPE2DR26FNL8M
- Not listed
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $3,768.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 10-320 mg on July 14, 2025, with completion expected by July 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,524.91 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on June 25, 2025, with completion targeted for June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $1,007.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 5-320 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,117.93. This firm fixed price delivery order, awarded on May 15, 2025, represents a non-set-aside competitive award with an ultimate completion date of May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.54 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and represents a single pharmaceutical supply transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,701.12 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 5-160-12.5 mg tablets (30-count package), a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on September 22, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,673.51 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Exforge is a combination antihypertensive medication used to treat...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,685 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 30 tablets of Exforge 10-160 mg to a location in Conshohocken, Pennsylvania, with performance required from August 15 through August 16, 2023. As a leading provider of pharmaceuticals and healthcare solutions to the Department of Defense, Amerisourcebergen will deliver the specified medication in support of...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL8MDelivery Order
The Defense Logistics Agency awarded a $2,699.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This non-set-aside, competitively awarded delivery order is scheduled for completion by November 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical federal medical procurement vendor, particularly for the Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This award reflects AmerisourceBergen's continued role in supporting federal medical supply chain requirements through its competitive performance and established capabilities under the DLA Troop Support Medical indefinite delivery contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/31/25 |